Pilot study of Flt3 ligand comparing intraperitoneal with subcutaneous routes on hematologic and immunologic responses in patients with peritoneal carcinomatosis and mesotheliomas. [electronic resource]
Producer: 20040719Description: 5228-37 p. digitalISSN:- 1078-0432
- Adjuvants, Immunologic -- administration & dosage
- Adult
- Aged
- Antigens, CD -- metabolism
- Carcinoma -- drug therapy
- Cytokines -- metabolism
- Dendritic Cells -- metabolism
- Female
- Gastrointestinal Neoplasms -- drug therapy
- Hematologic Tests
- Humans
- Injections, Intraperitoneal
- Injections, Subcutaneous
- Male
- Membrane Proteins -- administration & dosage
- Mesothelioma -- drug therapy
- Middle Aged
- Monocytes -- metabolism
- Ovarian Neoplasms -- drug therapy
- Peritoneal Neoplasms -- drug therapy
- Pilot Projects
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.